Sharp Says Biogen Idec Can Grow Alone or Be Acquired: Video

Описание: June 21 (Bloomberg) -- Phillip Sharp, co-founder of Biogen Idec Inc. and Alnylam Pharmaceuticals Inc., talks with Bloomberg's Mark Crumpton about the possibility that Biogen could be acquired and the outlook for the biotechnology industry and Alnylam.
Sharp retired from the board of Biogen last year and remains a board member at Alnylam. He won the Nobel Prize in Medicine in 1993 and is a biology professor at Massachusetts Institute of Technology. (Source: Bloomberg)